NK-92

Name: NK-92
Brand: Procell
SKU: CL-0530
Price: 500.0 USD
Availability: InStock

Copy the product info.

Cat. No.: CL-0530

Publications(60)

CL-0530

$ 500.00

Select a size

1×10^6Cells/Vial×2Vials

Quantity

- +

In stock

Inquire

For order requirements and technical needs, please Contact Us

Product Introduction Documents Publications

Product Introduction

General information

Cell Name	NK-92
Synonyms	NK92;Natural Killer-92;NK-92.05;Neukoplast;aNK
Cellosaurus Accession	CVCL_2142
Organism	Human
Growth Properties	Suspension
Morphology	Lymphoblast-like
Disease	lymphoma cells
Tissue	Peripheral blood
Age	50Y
Sex	Male

Handling information

Instructions	1. Check all containers for leakage or breakage. 2. Remove the frozen cells from the dry ice packaging and immediately transfer them to liquid nitrogen (liquid or vapor phase) for long-term cryopreservation. 3. This cell line is a suspension cell line. Harvest the cell suspension by centrifugation; do not discard the culture medium directly.
Complete Medium	Component one：MEMα [PM150422]+0.2 mM Inositol+0.1 mM Supplement1+0.02 mM Folic Acid+12.5% Nutrient2+12.5% Nutrient1+1% Supplement2 Component two：IL-2 [PB180634]
Incubation Atmosphere	Air, 95%; CO₂, 5%
Temperature	37℃
Subcultivation Ratio	5×10⁵-1×10⁶ cells/mL
Medium Renewal	2 to 3 times per week
Subculturing Procedure	Cultures can be maintained by either supplementing with fresh medium or exchanging medium via centrifugation. The recommended centrifugation conditions are 1200 rpm (approximately 250 × g) for 3 minutes.
Freeze Medium	Freezing Medium (Serum-free & animal origin-free) [PB180438]
Storage Conditions	For long-term cryopreservation, cryovials should be stored in liquid nitrogen at −150°C to −196°C. Storage at −80°C is restricted to short-term interim use only.

Reference materials

Background

The NK-92 cell line is an IL-2-dependent NK cell line derived from peripheral blood mononuclear cells of a 50-year-old Caucasian male with rapidly progressive non-Hodgkin's lymphoma. NK-92 cells are cytotoxic to a wide range of malignant cells; chromium release assays have demonstrated their ability to kill both K562 cells and Daudi cells. NK-92 cells (after irradiation to prevent proliferation) can be effectively used for immunological ex vivo purging of leukemia from blood without compromising hematopoietic cell function. NK-92 cells exhibit the following characteristics: positive for the surface markers CD2, CD7, CD11a, CD28, CD45, and CD54; negative for CD1, CD3, CD4, CD5, CD8, CD10, CD14, CD16, CD19, CD20, CD23, CD34, and HLA-DR.

Biosafety Level

BSL-2